Gastrointestinal pathogen panel, 6/14
June 2014—XTAG GPP from Luminex is a qualitative molecular multiplex test intended for the detection and identification of 11 gastrointestinal pathogens, including bacteria, viruses, and parasites.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
June 2014—XTAG GPP from Luminex is a qualitative molecular multiplex test intended for the detection and identification of 11 gastrointestinal pathogens, including bacteria, viruses, and parasites.
June 2014—QIAxpert from Qiagen is a high-speed UV/VIS spectrophotometer that enables laboratories to assess the quality and quantity of nucleic acids in up to 16 samples within just two minutes.
June 2014—Enzo’s quantitative, high-sensitivity ELISA kit for Alzheimer research enables identification and quantification of APP ∆C31.
June 2014—AccuCore released AccuPathology 5.0, which includes enhancements in direct support of CoPath, PowerPath, Millennium, and AP Easy LIS. The Lab Equipment module now has optional wireless wi-fi logging to eliminate manual recording of temperatures and humidity levels and includes alerts.
June 2014—HTG Molecular Diagnostics and OvaGene Oncology entered a manufacturing supply agreement in which OvaGene will design and develop its proprietary gene expression assays on HTG’s fully automated, extraction-free Edge Platform.
June 2014—Arlington Scientific received FDA Center for Biologics Evaluation and Research clearance for the ASiManager-AT in rapid plasma reagin (RPR) interpretation and screening of blood donors.
June 2014—Siemens Healthcare submitted a Premarket Approval application for its Advia Centaur HIV Ag/Ab Combo assay to the Food and Drug Administration.
June 2014—Siemens Healthcare launched the Hematek 3000 System, a semiautomated slide staining system that can stain up to 60 slides per hour.
June 2014—Leica Biosystems joined the GHX electronic trading exchange for U.S. customers. The GHX Exchange enables provider organizations to send their electronic data interchange (EDI) transactions through a single connection as opposed to multiple point-to-point EDI connections, thus allowing Leica’s customers to view their transactions and address discrepancies in real time.
June 2014—InSphero, working with researchers at the Medical University Innsbruck in Tyrol, Austria, published a study highlighting development of a novel 3D cell culture model for non-small cell lung cancer.